Literature DB >> 31939726

Exploring Dysregulated Signaling Pathways in Cancer.

Sabah Nisar1, Sheema Hashem1, Muzafar A Macha2,3, Santosh K Yadav1, Sankavi Muralitharan4, Lubna Therachiyil5, Geetanjali Sageena6, Hamda Al-Naemi7, Mohammad Haris1,7, Ajaz A Bhat1.   

Abstract

Cancer cell biology takes advantage of identifying diverse cellular signaling pathways that are disrupted in cancer. Signaling pathways are an important means of communication from the exterior of cell to intracellular mediators, as well as intracellular interactions that govern diverse cellular processes. Oncogenic mutations or abnormal expression of signaling components disrupt the regulatory networks that govern cell function, thus enabling tumor cells to undergo dysregulated mitogenesis, to resist apoptosis, and to promote invasion to neighboring tissues. Unraveling of dysregulated signaling pathways may advance the understanding of tumor pathophysiology and lead to the improvement of targeted tumor therapy. In this review article, different signaling pathways and how their dysregulation contributes to the development of tumors have been discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Angiogenesis; apoptosis; cell invasion; cell proliferation; drug targets; metastasis; signaling pathways; tumor microenvironment.

Year:  2020        PMID: 31939726     DOI: 10.2174/1381612826666200115095937

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Crocus sativus L. Tepal Extract Induces Apoptosis in Human U87 Glioblastoma Cells.

Authors:  Shoib Ahmad Baba; Maryam Vahedi; Irfan Ahmad; Bodour S Rajab; Ahmad O Babalghith; Safia Irfan; Md Jamal Hossain
Journal:  Biomed Res Int       Date:  2022-06-10       Impact factor: 3.246

Review 2.  Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Authors:  Ajaz A Bhat; Sabah Nisar; Selma Maacha; Tatiana Correa Carneiro-Lobo; Sabah Akhtar; Kodappully Sivaraman Siveen; Nissar A Wani; Arshi Rizwan; Puneet Bagga; Mayank Singh; Ravinder Reddy; Shahab Uddin; Jean-Charles Grivel; Gyan Chand; Michael P Frenneaux; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Muzafar A Macha; Mohammad Haris
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

3.  Association of sonic hedgehog signaling pathway genes IHH, BOC, RAB23a and MIR195-5p, MIR509-3-5p, MIR6738-3p with gastric cancer stage.

Authors:  Sadegh Fattahi; Novin Nikbakhsh; Mohammad Ranaei; Davood Sabour; Haleh Akhavan-Niaki
Journal:  Sci Rep       Date:  2021-04-02       Impact factor: 4.379

4.  CHIR99021, trough GSK-3β Targeting, Reduces Epithelioid Sarcoma Cell Proliferation by Activating Mitotic Catastrophe and Autophagy.

Authors:  Sabino Russi; Alessandro Sgambato; Anna Maria Bochicchio; Pietro Zoppoli; Michele Aieta; Alba Maria Lucia Capobianco; Vitalba Ruggieri; Emanuela Zifarone; Geppino Falco; Simona Laurino
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

Review 5.  Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis.

Authors:  Ashna Gupta; Ravi Chauhan; Tarang Sharma; Ajaz A Bhat; Sabah Nisar; Sheema Hashem; Sabah Akhtar; Aamir Ahmad; Mohammad Haris; Mayank Singh; Shahab Uddin
Journal:  Cancer Metastasis Rev       Date:  2022-05-05       Impact factor: 9.237

6.  Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC.

Authors:  Fei Xu; Qingkang Meng; Feng Wu; Yakun Wang; Wenjun Yang; Yun Tong; Lei Liu; Xiujie Chen
Journal:  Oxid Med Cell Longev       Date:  2022-09-05       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.